Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 374

1.

The "gender factor" in wearing-off among patients with Parkinson's disease: a post hoc analysis of DEEP study.

Colombo D, Abbruzzese G, Antonini A, Barone P, Bellia G, Franconi F, Simoni L, Attar M, Zagni E, Haggiag S, Stocchi F.

ScientificWorldJournal. 2015;2015:787451. doi: 10.1155/2015/787451. Epub 2015 Jan 20.

2.

Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease.

Biundo R, Weis L, Facchini S, Formento-Dojot P, Vallelunga A, Pilleri M, Weintraub D, Antonini A.

Mov Disord. 2015 Feb 4. doi: 10.1002/mds.26154. [Epub ahead of print]

PMID:
25649923
3.

The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: A simple grading system.

Chaudhuri KR, Sauerbier A, Rojo JM, Sethi K, Schapira AH, Brown RG, Antonini A, Stocchi F, Odin P, Bhattacharya K, Tsuboi Y, Abe K, Rizos A, Rodriguez-Blazquez C, Martinez-Martin P.

Parkinsonism Relat Disord. 2015 Mar;21(3):287-91. doi: 10.1016/j.parkreldis.2014.12.031. Epub 2015 Jan 5.

PMID:
25616694
4.

Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.

Samuel M, Rodriguez-Oroz M, Antonini A, Brotchie JM, Ray Chaudhuri K, Brown RG, Galpern WR, Nirenberg MJ, Okun MS, Lang AE.

Mov Disord. 2015 Feb;30(2):150-9. doi: 10.1002/mds.26099. Epub 2015 Jan 21.

PMID:
25607799
5.

Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes.

Antonini A, Yegin A, Preda C, Bergmann L, Poewe W; GLORIA study investigators and coordinators.

Parkinsonism Relat Disord. 2015 Mar;21(3):231-5. doi: 10.1016/j.parkreldis.2014.12.012. Epub 2014 Dec 19.

6.

Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesias.

Stathis P, Konitsiotis S, Antonini A.

Expert Rev Neurother. 2015 Feb;15(2):207-13. doi: 10.1586/14737175.2015.1001747. Epub 2015 Jan 12.

PMID:
25578445
7.

Clinical variables associated with treatment changes in Parkinson's disease: results from the longitudinal phase of the REASON study.

Abbruzzese G, Barone P, Ceravolo R, Fabbrini G, Lessi P, Ori A, Simoni L, Tinazzi M, Antonini A.

Neurol Sci. 2015 Jan 7. [Epub ahead of print]

PMID:
25564417
8.

Therapeutic strategies to prevent and manage dyskinesias in Parkinson's disease.

Pilleri M, Antonini A.

Expert Opin Drug Saf. 2015 Feb;14(2):281-94. doi: 10.1517/14740338.2015.988137. Epub 2014 Dec 6.

PMID:
25483147
9.

Novel formulations and modes of delivery of levodopa.

Poewe W, Antonini A.

Mov Disord. 2015 Jan;30(1):114-20. doi: 10.1002/mds.26078. Epub 2014 Dec 5.

PMID:
25476691
10.

Peripheral nervous system involvement in Parkinson's disease: evidence and controversies.

Comi C, Magistrelli L, Oggioni GD, Carecchio M, Fleetwood T, Cantello R, Mancini F, Antonini A.

Parkinsonism Relat Disord. 2014 Dec;20(12):1329-34. doi: 10.1016/j.parkreldis.2014.10.010. Epub 2014 Oct 18.

11.

EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease.

Martinez-Martin P, Reddy P, Katzenschlager R, Antonini A, Todorova A, Odin P, Henriksen T, Martin A, Calandrella D, Rizos A, Bryndum N, Glad A, Dafsari HS, Timmermann L, Ebersbach G, Kramberger MG, Samuel M, Wenzel K, Tomantschger V, Storch A, Reichmann H, Pirtosek Z, Trost M, Svenningsson P, Palhagen S, Volkmann J, Chaudhuri KR.

Mov Disord. 2014 Nov 10. doi: 10.1002/mds.26067. [Epub ahead of print]

PMID:
25382161
12.

Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: an international multicenter study.

Rizos A, Martinez-Martin P, Odin P, Antonini A, Kessel B, Kozul TK, Todorova A, Douiri A, Martin A, Stocchi F, Dietrichs E, Chaudhuri KR; EUROPAR and the IPDMDS non-Motor PD Study Group.

Parkinsonism Relat Disord. 2014 Nov;20(11):1231-5. doi: 10.1016/j.parkreldis.2014.09.013. Epub 2014 Sep 16.

PMID:
25269446
13.

Buckwheat achenes antioxidant profile modulates Aspergillus flavus growth and aflatoxin production.

Chitarrini G, Nobili C, Pinzari F, Antonini A, De Rossi P, Del Fiore A, Procacci S, Tolaini V, Scala V, Scarpari M, Reverberi M.

Int J Food Microbiol. 2014 Oct 17;189:1-10. doi: 10.1016/j.ijfoodmicro.2014.07.029. Epub 2014 Jul 28.

PMID:
25108759
14.

Adenosine A2A receptor antagonists in Parkinson's disease: still in the running.

Antonini A, Poewe W.

Lancet Neurol. 2014 Aug;13(8):748-9. doi: 10.1016/S1474-4422(14)70153-X. Epub 2014 Jul 6. No abstract available.

PMID:
25008550
15.

Parkinson disease: Can dopamine transporter imaging define early PD?

Antonini A, Biundo R.

Nat Rev Neurol. 2014 Aug;10(8):432-3. doi: 10.1038/nrneurol.2014.123. Epub 2014 Jul 8. No abstract available.

PMID:
25002108
16.

Fluorescent layers for characterization of sectioning microscopy with coverslip-uncorrected and water immersion objectives.

Antonini A, Liberale C, Fellin T.

Opt Express. 2014 Jun 16;22(12):14293-304. doi: 10.1364/OE.22.014293.

PMID:
24977527
17.

Skin cancer risk in autoimmune connective tissue diseases.

Kostaki D, Antonini A, Peris K, Fargnoli MC.

G Ital Dermatol Venereol. 2014 Oct;149(5):567-72. Epub 2014 Jun 30. Review.

PMID:
24975951
18.

Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy.

Vallelunga A, Ragusa M, Di Mauro S, Iannitti T, Pilleri M, Biundo R, Weis L, Di Pietro C, De Iuliis A, Nicoletti A, Zappia M, Purrello M, Antonini A.

Front Cell Neurosci. 2014 Jun 10;8:156. doi: 10.3389/fncel.2014.00156. eCollection 2014.

19.

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies.

Krismer F, Jellinger KA, Scholz SW, Seppi K, Stefanova N, Antonini A, Poewe W, Wenning GK.

Parkinsonism Relat Disord. 2014 Aug;20(8):793-9. doi: 10.1016/j.parkreldis.2014.05.005. Epub 2014 May 21.

20.

Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group.

Stankovic I, Krismer F, Jesic A, Antonini A, Benke T, Brown RG, Burn DJ, Holton JL, Kaufmann H, Kostic VS, Ling H, Meissner WG, Poewe W, Semnic M, Seppi K, Takeda A, Weintraub D, Wenning GK; Movement Disorders Society MSA (MODIMSA) Study Group.

Mov Disord. 2014 Jun;29(7):857-67. doi: 10.1002/mds.25880. Epub 2014 Apr 18. Review.

PMID:
24753321
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk